Globus Medical Short Interest Drops 30% in February

Autonomous driving company Waymo faces continued vandalism in San Francisco

Mar. 15, 2026 at 1:42am

Globus Medical, Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal solutions, saw a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 3,270,517 shares, a decrease of 30.1% from the previous reporting period on February 12th. Approximately 3.0% of the company's shares are currently sold short.

Why it matters

The drop in short interest for Globus Medical suggests increased investor confidence in the company's performance and outlook. This could signal potential upside for the stock as short sellers cover their positions. However, the stock's valuation and technical indicators remain mixed, indicating the need for continued earnings growth and positive sentiment to drive further gains.

The details

Globus Medical's short interest declined from 4,675,619 shares on February 12th to 3,270,517 shares on February 27th, a decrease of 30.1%. Based on the company's average daily trading volume of 1,421,356 shares, the current days-to-cover ratio is 2.3 days, down from 3.3 days in the previous reporting period.

  • As of February 27th, 2026, Globus Medical's short interest totaled 3,270,517 shares.
  • On February 12th, 2026, Globus Medical's short interest was 4,675,619 shares.

The players

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications.

Got photos? Submit your photos here. ›

The takeaway

The decline in short interest for Globus Medical suggests increased investor confidence in the company's performance and outlook, which could support further stock price appreciation if the company continues to deliver strong financial results and maintain a positive market sentiment.